like some of their RECAF claims when the share price ran from .20 to $3.50 in two days. I'm waiting for that cloud to lift as the Abbot Labs deal confirms the product claims IMO.
"If" RECAF proves out this little company could have an enourmous share price but it will require time and patients.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.